<bill session="118" type="s" number="2493" updated="2024-10-09T21:58:54Z">
  <state datetime="2023-07-25">REFERRED</state>
  <status>
    <introduced datetime="2023-07-25"/>
  </status>
  <introduced datetime="2023-07-25"/>
  <titles>
    <title type="display">PBM Reporting Transparency Act</title>
    <title type="short" as="introduced">PBM Reporting Transparency Act</title>
    <title type="official" as="introduced">A bill to require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on arrangements with pharmacy benefit managers with respect to prescription drug plans MA-PD plans.</title>
  </titles>
  <sponsor bioguide_id="W000805"/>
  <cosponsors>
    <cosponsor bioguide_id="C001113" joined="2023-07-25"/>
    <cosponsor bioguide_id="T000250" joined="2023-07-25"/>
    <cosponsor bioguide_id="T000476" joined="2023-07-25"/>
  </cosponsors>
  <actions>
    <action datetime="2023-07-25">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-07-25" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2024-10-09T21:58:22Z" status="Introduced in Senate">PBM Reporting Transparency Act

This bill requires the Medicare Payment Advisory Commission to report certain information about pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage.

Specifically, the commission must report on trends in agreements between PBMs and prescription drug plans, the impact of any differences in agreements on out-of-pocket spending for enrollees and pharmacy reimbursements, and any appropriate recommendations. The commission must submit an updated report two years after its initial report.</summary>
</bill>
